| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |